StockData
Satellos Bioscience Inc. logo

Satellos Bioscience Inc. (MSLE) stock

MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 27, 2026Score 5/30
$5.94−0.26 (-4.19%)

Close on Nov 18, 2026Market cap $91.83MP/E –Yield –

Satellos Bioscience operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$26.46M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$26.46M–
FY2024Dec 31, 2024-$20.40M–

More Satellos Bioscience figures

See a number that looks wrong?